Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB)
CUSIP: G23549101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 62,075,472
- Total 13F shares
- 1,621,133
- Share change
- +1,621,133
- Total reported value
- $2,443,403
- Price per share
- $1.48
- Number of holders
- 15
- Value change
- +$2,443,403
- Number of buys
- 15
Quarterly Holders Quick Answers
What is CUSIP G23549101?
CUSIP G23549101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2025
Recent filing periods for CUSIP G23549101:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Panacea Innovation Ltd |
13D/G
|
Panacea Innovation Limited |
25%
|
13,950,000
|
$13,950,000 | $0 | 21 Jul 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
3.3%
|
1,821,558
|
$1,785,127 | — | 30 Jun 2025 | |
| CHOREO, LLC |
13F
|
Company |
0.29%
|
160,867
|
$157,650 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.26%
|
143,700
|
$140,826 | — | 30 Jun 2025 | |
| AlphaCore Capital LLC |
13F
|
Company |
0.14%
|
80,000
|
$78,400 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.11%
|
61,992
|
$61,992 | — | 30 Jun 2025 | |
| Koa Wealth Management, LLC |
13F
|
Company |
0.09%
|
49,600
|
$48,608 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.07%
|
40,400
|
$40,000 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.05%
|
28,862
|
$28,862 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
23,320
|
$23,320 | — | 30 Jun 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
20,000
|
$20,000 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.02%
|
10,300
|
$10,094 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
2,370
|
$2,370 | — | 30 Jun 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
1,582
|
$1,550 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
121
|
$121 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
100
|
$98 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
42
|
$41 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
6
|
$6 | — | 30 Jun 2025 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) as of Q3 2025
As of 30 Sep 2025,
Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,621,133 shares.
The largest 10 holders included
BML Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, Koa Wealth Management, LLC, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MONOGRAPH WEALTH ADVISORS, LLC, HRT FINANCIAL LP, and CITIGROUP INC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q3 2025 Across Filers
Q3 2025 holders
15
Q3 2025 holders
15
Holder diff
0
| Investor | Q3 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.